Gsa Capital Partners LLP Orchard Therapeutics PLC Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.42 - $0.78 $101,692 - $188,858	242,126 Added 64.69%	616,402 $360,000
Q1 2022 May 11, 2022	BUY	$0.7 - $1.51 $24,864 - $53,635	35,520 Added 10.49%	374,276 $266,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $41,823 - $80,402	-36,055 Reduced 9.62%	338,756 $447,000
Q3 2021 Nov 12, 2021	BUY	$2.24 - $4.29 $839,576 - $1.61 Million	374,811 New	374,811 $862,000
Q2 2021 Aug 05, 2021	SELL	$4.39 - $7.23 $1.21 Million - $2 Million	-276,381 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$4.39 - $9.08 $1.17 Million - $2.41 Million	265,685 Added 2483.97%	276,381 $2.01 Million
Q4 2020 Feb 03, 2021	SELL	$3.86 - $5.07 $2,512 - $3,300	-651 Reduced 5.74%	10,696 $46,000
Q3 2020 Nov 06, 2020	SELL	$4.11 - $6.45 $38,469 - $60,372	-9,360 Reduced 45.2%	11,347 $47,000
Q2 2020 Aug 11, 2020	BUY	$5.75 - $11.99 $119,065 - $248,276	20,707 New	20,707 $124,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.